ERBB2 and neoplasm: ERBB2, NRG4, and MIG6 serum levels were compared based on tumor characteristics, including BCLC stage, tumor-maximal diameter, and the number of tumors, using the Kruskal–Wallis test and bivariate (Spearman) correlation (Table 2).